A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers.
Saved in:
| Title: | A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers. |
|---|---|
| Authors: | Tao, Ye1 (AUTHOR), Li, Ting1 (AUTHOR), Lin, Pingping1 (AUTHOR), Jiang, Xin1 (AUTHOR), Shi, Ping1 (AUTHOR), Fu, Yao1 (AUTHOR), Liu, Xin2 (AUTHOR), Wang, Chenjing1 (AUTHOR), Li, Shaorong3 (AUTHOR), Li, Xiaofeng3 (AUTHOR), Cao, Yu1 (AUTHOR) caoyu@qdu.edu.cn |
| Source: | Clinical Pharmacology in Drug Development. Jan2023, Vol. 12 Issue 1, p65-69. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.1182 |
